GDR

Hardman & Co

Genedrive Regulatory hurdle leaped: hearing loss assay

Genedrive (LON:GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use device with

Hardman & Co

Genedrive – Acceleration of news flow expected

Genedrive plc (LON:GDR) is the topic of conversation when Dr Dorothea Hill joins DirectorsTalk. After releasing a note anticipating accelerated news flow from Genedrive Dorothea gives us an update as to

Hardman & Co

Genedrive plc Accelerating into fiscal 2019 with first sales

Genedrive plc (LON:GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic testing platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use

Hardman & Co

Genedrive plc Preventing hearing loss in newborns

Genedrive plc (LON:GDR) is a commercial-stage company focused on point-of-care molecular diagnostics. Its Genedrive® molecular diagnostic testing platform is at the forefront of this technology, offering a rapid, low-cost, simple-to-use

Hardman & Co

genedrive plc Remodelled for growth

genedrive plc (LON:GDR) is a commercial-stage company focused on point-of-care/need molecular diagnostics and biomarkers. Its Genedrive® in vitro diagnostic testing platform is at the forefront of this technology, offering a